Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement
Author(s) -
Michael A.S. Jewett,
Jennifer J. Knox,
Christian Kollmannsberger
Publication year - 2013
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.567
Subject(s) - kidney cancer , statement (logic) , cancer , medicine , kidney , oncology , political science , law
• History and physical examination • Laboratory tests: CBC, LDH, metabolic panel (creatinine, electrolytes, AST, ALT, alkaline phosphatase, bilirubin, INR, PTT, calcium, magnesium, phosphate, albumin), urinalysis and urine cytology • Imaging • Primary tumour i. Abdominal/pelvic CT with and without intravenous contrast ii. Abdominal MRI if CT suggests caval thrombus or because of a contrast allergy or renal insufficiency • Metastatic evaluation i. Chest radiograph, consider CT chest if ≥ stage T2 ii. Bone scan, if clinically indicated or elevated alkaline phosphatase iii. Brain MRI, if clinically indicated A suspicious renal mass that enhances by Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement CONSENSUS GUIDELINE
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom